I recently shared a BMJ report that outlined the approval of Esketamine in Europe: Since sharing this news, the following rapid response by the MHRA [The Medicines and Healthcare products … Continue reading Esketamine: Regulators and a confusing narrative
The BMJ has published this News report, the full article can be accessed here.
3rd October 2018, Fiona Godlee, Editor-in-Chief of the BMJ: “We need a Sunshine Act to ensure that payments are properly declared. We also need action from medicines’s leaders – the … Continue reading Sunshine, light, and the Royal College of Psychiatrists
Yesterday, on the 29th May 2018 I had my last revalidation as a doctor [though I will still have to complete annual appraisals until I retire in 2022]. My experience … Continue reading ‘We must look at the whole impact of revalidation’